Gainers
- Allogene Therapeutics (NASDAQ:ALLO) shares increased by 12.7% to $7.98 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.1 billion.
- LogicBio Therapeutics (NASDAQ:LOGC) stock increased by 11.6% to $0.48. The company's market cap stands at $15.8 million. As per the press release, Q1 earnings came out yesterday.
- Cellectis (NASDAQ:CLLS) shares moved upwards by 10.5% to $3.47. The company's market cap stands at $157.8 million. As per the news, the Q1 earnings report came out 3 days ago.
- Inhibrx (NASDAQ:INBX) stock moved upwards by 10.12% to $15.12. The company's market cap stands at $590.2 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 9.14% to $1.79. The company's market cap stands at $9.7 million.
- Blue Water Vaccines (NASDAQ:BWV) shares rose 9.02% to $4.47. The market value of their outstanding shares is at $57.3 million. As per the press release, Q1 earnings came out 2 days ago.
Losers
- AnPac Bio-Medical Science (NASDAQ:ANPC) stock declined by 18.7% to $0.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.1 million.
- Aspira Womens Health (NASDAQ:AWH) shares decreased by 17.99% to $0.48. The company's market cap stands at $53.3 million. As per the news, the Q1 earnings report came out 4 days ago.
- Cullinan Oncology (NASDAQ:CGEM) shares declined by 11.77% to $9.6. The market value of their outstanding shares is at $429.9 million. As per the news, the Q1 earnings report came out yesterday.
- Acer Therapeutics (NASDAQ:ACER) stock fell 10.2% to $1.85. The company's market cap stands at $28.3 million. As per the news, the Q1 earnings report came out yesterday.
- Adamis Pharmaceuticals (NASDAQ:ADMP) stock fell 9.6% to $0.42. The company's market cap stands at $62.8 million. The company's, Q1 earnings came out yesterday.
- Connect Biopharma Hldgs (NASDAQ:CNTB) shares decreased by 9.33% to $0.73. The market value of their outstanding shares is at $40.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
